EXTRACTABLE NUCLEAR ANTIGENS ENA/ANTI NUCLEAR ANTIBODIES ANA QUALITATIVE PROFILE Test
At DNA Labs UAE, we offer the EXTRACTABLE NUCLEAR ANTIGENS ENA/ANTI NUCLEAR ANTIBODIES ANA QUALITATIVE PROFILE Test. This diagnostic test is designed to detect and identify specific antibodies in the blood that target nuclear antigens. These antibodies are associated with autoimmune diseases such as systemic lupus erythematosus (SLE) and Sjgren’s syndrome.
Test Details
The ENA/ANA Qualitative Profile test is a combined group screening test for 15 antigens. It is priced at 1100.0 AED. To perform the test, a 2 mL (1 mL min.) serum sample from 1 SST is required. The sample should be shipped refrigerated or frozen. The report delivery is available from Monday through Saturday by 9 am, with the report being delivered on the same day.
Method
The test is performed using the immunoblot method, which is commonly used for autoimmune disorder testing. The test type is specifically designed to detect autoimmune disorders, and it is recommended to consult with a physician or rheumatologist for this test.
Test Department
The ENA/ANA Qualitative Profile test is conducted in our Immunopathology department by experienced technicians.
Pre Test Information
No special preparation is required before undergoing the ENA/ANA Qualitative Profile test.
Test Components
The ENA panel typically includes antibodies against several nuclear antigens, including Ro (SSA), La (SSB), Sm, RNP, and Jo-1. The ANA test, on the other hand, detects general antibodies that bind to various components of the cell nucleus.
Test Results and Diagnosis
A positive result for the ENA/ANA test indicates the presence of specific antibodies in the blood, suggesting an autoimmune disease. However, it is important to note that a positive result does not confirm a diagnosis of a specific autoimmune disease. Further clinical evaluation and additional tests may be required to confirm the diagnosis and determine the specific autoimmune condition.
Benefits of the Test
The ENA/ANA Qualitative Profile test is a valuable tool for diagnosing and monitoring autoimmune diseases. It allows healthcare providers to tailor treatment plans and provide appropriate care to patients.
| Test Name | EXTRACTABLE NUCLEAR ANTIGENS ENAANTI NUCLEAR ANTIBODIES ANA QUALITATIVE PROFILE Test |
|---|---|
| Components | Combinedgroupscreening test for15 antigens |
| Price | 1100.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
| Report Delivery | SampleMonthrough Sat by 9 am; Report Same day |
| Method | Immunoblot |
| Test type | Autoimmune disorders |
| Doctor | Physician, Rheumatologist |
| Test Department: | IMMUNOPATHOLOGY |
| Pre Test Information | No special preparation required |
| Test Details | The Extractable Nuclear Antigens (ENA)/Anti Nuclear Antibodies (ANA) Qualitative Profile test is a diagnostic test used to detect and identify specific antibodies in the blood that target nuclear antigens. These antibodies are associated with autoimmune diseases such as systemic lupus erythematosus (SLE) and Sjgren’s syndrome. During the test, a blood sample is taken from the patient and sent to a laboratory for analysis. The laboratory technicians will use various techniques, such as enzyme-linked immunosorbent assay (ELISA) or immunofluorescence, to detect the presence of specific antibodies in the blood. The ENA panel typically includes antibodies against several nuclear antigens, including Ro (SSA), La (SSB), Sm, RNP, and Jo-1. The ANA test, on the other hand, detects general antibodies that bind to various components of the cell nucleus. A positive result for the ENA/ANA test indicates the presence of these specific antibodies in the blood, suggesting an autoimmune disease. However, it is important to note that a positive result does not necessarily confirm a diagnosis of a specific autoimmune disease. Further clinical evaluation and additional tests may be required to confirm the diagnosis and determine the specific autoimmune condition. The ENA/ANA Qualitative Profile test is a valuable tool for diagnosing and monitoring autoimmune diseases, allowing healthcare providers to tailor treatment plans and provide appropriate care to patients. |
